Aurora, CO, United States of America

Rooban B Nahomi

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Rooban B Nahomi

Introduction

Rooban B Nahomi is an accomplished inventor based in Aurora, Colorado. He has made significant contributions to the field of ocular health through his innovative patents. With a total of two patents to his name, Nahomi is dedicated to advancing medical treatments for eye conditions.

Latest Patents

Nahomi's latest patents include groundbreaking methods for treating ocular conditions. One of his notable inventions is related to aggrelytes for treating presbyopia. This method involves administering a pharmaceutically effective amount of an aggrelyte, which may include compounds such as N,S-diacetyl-L-cysteine methyl ester, S-acetyl-N-(3,3,-dimethylbutanoyl)-L-cysteinate, or N-acetyl cysteine methyl ester. The aggrelyte can be administered topically to the subject. Another significant patent focuses on methods for preventing and treating retinal damage. This involves administering kynurenic acid to treat, reduce the risk of, or alleviate symptoms of retinal diseases. The kynurenic acid may be administered intravenously or intravitreally, and the patent also discloses systems for treating retinal conditions that may include an administration device.

Career Highlights

Rooban B Nahomi is affiliated with the University of Colorado, where he continues to work on innovative solutions in ocular health. His research and inventions have the potential to significantly impact the treatment of eye diseases and conditions.

Collaborations

Nahomi collaborates with esteemed colleagues such as Ram H Nagaraj and Sandip Nandi, contributing to a dynamic research environment focused on ocular innovations.

Conclusion

Rooban B Nahomi's work exemplifies the spirit of innovation in the medical field, particularly in the treatment of ocular conditions. His patents reflect a commitment to improving patient outcomes and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…